Refine by
Metabolism Cell Articles & Analysis
27 news found
Researchers are working relentlessly to better understand tumor metabolism and to find new therapeutic strategies. Two recent studies highlight how critical glutamine metabolism is in breast cancer cells: ...
Attendees will learn why temperature and osmolality in cell culture are critical parameters affecting cell growth, viability and the concentration of HCPs in the supernatant. ...
CD BioGlyco, a biotechnology company that provides multi-omics analysis of cancer cell glycolysis including genomics, proteomics, metabolomics and metabolic fluxomics, now offers analysis of glycolytic enzymes in cancer cells, enabling thorough understanding of cancer cell glycolysis pathways. ...
They are commonly known as the powerhouses of the cell, generating most of its needed energy and operating as critical intra-cellular communication nodes. ...
Further to the announcement of the exclusive option to license the CORE-NK platform released on 21 November 2022, at the request of the ASX, Chimeric Therapeutics (ASX: CHM, “Chimeric”), a clinical-stage cell therapy company and an Australian leader in cell therapy, provides additional information regarding an exclusive license agreement with Case ...
The CORE-NK platform uses a novel, proprietary genetically-modified feeder cell line to activate and expand universal off-the-shelf allogeneic NK cell products derived from healthy donors. The expanded CORE-NK cells exhibit enhanced cytotoxicity, metabolism, and expression of activating receptors compared to fresh, activated NK ...
(“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today the publication of a preclinical study demonstrating therapeutic capabilities of its SAT1 cancer marker in glioblastoma (GB) cells using an ionizable lipid nanoparticle. The study published as part of ...
Gather self-energy to repair, one month after operation, whether self-repair nutrition is sufficient and cell repair results. 3. Generate new cells, 2-6 months after surgery, new cells are not necessarily young cells. After the age of 26, human cells enter natural aging. If there is no human intervention, each ...
The accumulation of blood toxins in the body, the decline in the blood’s ability to carry and supply oxygen, and the poor blood microcirculation make skin cells unable to obtain the oxygen and nutrients required for normal metabolism and damage. Due to the normal metabolic environment of skin cells, and the exposed facial ...
It refers to the use of a laser with a pulse width of picoseconds to act on the target cells, which can generate "mechanical waves" on the target base. The high energy generated instantly by the wave can gasify the cells, and the pigment particles in the cells are completely shattered into dust, can be better taken up and ...
CD BioSciences, a US-based life science research product supplier and CRO, proudly offers AMPK Pathway to the life science community for researchers focusing on diabetes and metabolism study. These new signaling pathways and previously launched metabolic signaling pathways, such as insulin signaling pathway and mTOR pathway, will help support scientists in all ...
The collaboration will take advantage of Charles River’s end-to-end CDMO capabilities, building on the Company’s acquisitions of Cognate BioServices, Cobra Biologics, and Vigene Biosciences in 2021 that expanded its comprehensive cell and gene therapy portfolio to span each of the major CDMO platforms – cell therapy, viral vector and plasmid DNA ...
ASC Therapeutics, a privately held biopharmaceutical company pioneering the development of transformative in-vivo gene replacement, gene editing and allogeneic cell therapies has joined as a full partner the Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (AMP® BGTC) including the National Institutes of Health (NIH) and the Food and Drug Administration ...
As compared to MSUD patients, MSUD calves exhibit a similar phenotype and are closely matched for size and metabolic rate. Without treatment they exhibit cerebral edema by day of life 3 and die soon after. ...
” The Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) is the world’s largest gathering of gene and cell therapy professionals and provides an international forum where the latest scientific discoveries are presented and discussed. ...
ASC Therapeutics, a privately held biopharmaceutical company pioneering the development of transformative in-vivo gene replacement, gene editing and allogeneic cell therapies for hematologic, metabolic, and other rare diseases has received from the United States (U.S.) ...
Bilirubin is a yellow-brown substance present in bile and is a product produced when hemoglobin, a component of red blood cells, is metabolized when worn-out red blood cells are decomposed. Increased levels of bilirubin cause jaundice, a yellowing of the skin or whites of the eyes. ...
Bilirubin is a yellowish-brown substance present in bile that is produced when hemoglobin, a component of red blood cells, is metabolized when red blood cells that have reached the end of their life are decomposed. ...
Errors in centromere or kinetochore function are catastrophic for the cell. This error can lead to abnormal division and chromosomal instability, both of which are frequently observed in cancer cells. ...
Harvard spinout cellvie is pioneering therapeutic mitochondria transplantation as a way to rescue cell energy metabolism and save cells that would otherwise die. James McCully, a cellvie AG co-founder, developed the approach at Harvard Medical School to ameliorate ischemia-reperfusion injury, which is the tissue damage caused when the blood ...